Hep3B cells stably overexpressing GSTK1 were subcutaneously injected into BALB/c-Nude mice to assess the impact of bexarotene on HCC in vivo, then subsequently gavaged with bexarotene (100 mg/kg) every day (Fig. 7N). This evidence concerns the gene GSTK1 and hepatocellular carcinoma.